Complete pathological response to olaparib and bevacizumab in advanced cervical cancer following chemoradiation in a BRCA1 mutation carrier: a case report

Peer Review reports

Original Submission
2 Apr 2020	Submitted	Original manuscript
29 Dec 2020	Reviewed	Reviewer Report - Stergios Boussios
10 Jan 2021	Reviewed	Reviewer Report - Malik Mohamed ATOUI
16 Feb 2021	Author responded	Author comments - Rosa Montero-Macias
Resubmission - Version 2
16 Feb 2021	Submitted	Manuscript version 2
Publishing
1 Mar 2021	Editorially accepted
23 Apr 2021	Article published	10.1186/s13256-021-02767-9

Back to article page